Back to Results
| First Page | Meta Content | |
|---|---|---|
 | Document Date: 2012-06-03 04:08:11Open Document File Size: 1,16 MBShare Result on FacebookCompanyFILER APPLIED BIOSYSTEMS INC. / Atom Acquisition LLC / Applera Corporation / The Perkin-Elmer Corporation / FINANCIAL STATEMENT SCHEDULE 67 APPLIED BIOSYSTEMS INC. / Applied Biosystems Inc. / Abbott Molecular / Morgan Stanley / Invitrogen Corporation / Celera Group / Abbott Laboratories / Berkeley HeartLab Inc. / Celera Corporation / New York Stock Exchange / Participating Junior N/A Preferred Stock (par value $0.01 per share) Securities / /CurrencyUSD / /EventM&A / Dividend Issuance / Employment Change / Reorganization / Name Change / Business Partnership / /IndustryTermtechnology solutions / molecular diagnostic products / pharmaceutical research / disease management / disease management services / agricultural biotechnology / recently-acquired subsidiary / manufacturing / protein analysis solutions / s telephone number / personalized disease management / healthcare providers / licensed other relevant diagnostic technologies / direct wholly-owned subsidiary / /Organizationofficers of the Registrant Item 1A / UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON / D.C. / Internal Revenue Service / I.R.S. / Audit Committee / Securities and Exchange Commission / /PersonStevenson / / /PositionSenior Vice President of our company and President and Chief Operating Officer / Vice President of the company and Executive Vice President / Executive / President and Chief Operating Officer / Principal Accountant / Director Independence Item / /ProductPentax K-x Digital Camera / /ProvinceOrStateDelaware / Incorp / /TechnologyProteomics / drug discovery / biotechnology / relevant diagnostic technologies / HTML / /URLwww.secdatabase.com / /SocialTag |